The current European HealthTech and MedTech landscape presents a compelling and timely opportunity for specialised Private Equity (PE) deployment, driven by a simultaneous market correction and entrenched structural fragmentation. Following the "exuberance" and peak valuations of the COVID-19-driven Venture Capital (VC) boom of 2021–2022, a significant shift in investor sentiment has occurred. High interest rates and inflation have elevated the cost of capital, forcing in

Major developments in European HealthTech this week have been dominated by major funding rounds in biotech, significant regulatory alignment and continued investment in digital health. The last week in European MedTech has been dominated by regulatory and funding activities, as well as continued momentum in digital health and surgical innovation.

The major stories in the world of European MedTech this week are dominated by regulatory activity under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), a significant European Commission "Call for Evidence" for future reforms, and fresh funding for companies focused on connected and remote monitoring devices.